Douglas B. Young, PhD

Imperial College London
UK National Institute for Medical Research

Douglas B. Young is the Fleming Professor of Medical Microbiology at Imperial College London and Head of the Division of Mycobacterial Research at the UK National Institute for Medical Research. He leads an international consortium to develop drugs for treatment of latent TB as part of The Bill and Melinda Gates Foundation programme to tackle Grand Challenges in Global Health. He is a member of the Board of Directors of the Aeras Global TB Vaccine Foundation and of the steering committee of the European TB Vaccine Initiative. He coordinates a Wellcome Trust project to study bovine TB in Ethiopia and chairs the TB Vaccine Programme Advisory Group for the UK Department of Environment, Food and Rural Affairs.

Dr. Young is the author of over 100 scientific articles on tuberculosis and leprosy, is co-Editor-in-Chief of Tuberculosis and a member of the Editorial Boards of Cellular Microbiology, Journal of Bacteriology and Infection and Immunity. His current research focuses on the use of genome biology to study mechanisms of mycobacterial pathogenicity. He earned his BSc degree from the University of Edinburgh and his PhD from the University of Oxford, both in biochemistry. He is a member of the UK Academy of Medical Sciences.